May 21, 2024

MicroRNA Market Size To Cross USD 7,757.01 Mn By 2032

The global microRNA market size accounted for US$ 1,252.80 Mn in 2022 and is projected to reach around USD 1,252.80 Mn by 2032, growing at a CAGR of 20% from 2023 to 2032.

MicroRNA Market Size 2023 To 2032

Report Summary

The global microRNA market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the microRNA market across the globe.

A comprehensive estimate on the microRNA market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of microRNA during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3023

 MicroRNA Market  Report Scope

Report CoverageDetails
Market Size in 2023USD 1,503.36 Million
Market Size by 2032USD 7,757.01 Million
Growth Rate from 2023 to 2032CAGR of 20%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Products, By Services, By Application, and By End Use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized microRNA market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Sequencing Reagents Market Size To Cross USD 13.43 Bn By 2032

 MicroRNA Market Players

The report includes the profiles of key microRNA market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Merck KGaA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Synlogic
  • GeneCopoeia, Inc
  • Horizon Discovery Ltd.
  • New England Biolabs
  • Quantabio
  • NanoString
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotec
  • Agilent Technologies, Inc
  • Promega Corporation
  • Abcam plc
  • KANEKA CORPORATION

Market Segmentation

By Products

  • Instruments
  • Consumables

By Services

  • Service Type
    • Isolation & Purification
    • miRNA cDNA Synthesis
    • Profiling, Localization, & Quantification
    • Functional Analysis
      • Real Time PCR
      • Microarray
      • NGS
      • Others
  • Specimen
    • Whole Blood
    • Serum
    • Plasma
    • FFPE
    • Fresh Frozen Tissue
    • Others

By Application

  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others

By End Use

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Other end-users

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MicroRNA Market 

5.1. COVID-19 Landscape: MicroRNA Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MicroRNA Market, By Products

8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Consumables

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global MicroRNA Market, By Services

9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2023-2032

9.1.1. Service Type

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Specimen

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global MicroRNA Market, By Application 

10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2023-2032

10.1.1. Cancer

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Infectious Diseases

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Immunological Disorder

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Cardiovascular Disease

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Neurological Disease

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global MicroRNA Market, By End Use 

11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2023-2032

11.1.1. Biotechnology & Pharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Academic & Government Research Institutes

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Other end-users

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)

Chapter 13. Company Profiles

13.1. Merck KGaA

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. QIAGEN

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Synlogic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GeneCopoeia, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Horizon Discovery Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. New England Biolabs

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Quantabio

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. NanoString

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. BioGenex

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com